Chinese medicine combination for preventing and curing lung injury and pulmonary fibrosis and preparation method thereof

Hai Guo,Jiening Gong,Baorui Liu,Xiaofei Chen,Jingdong He,Lixia Dong,Yan Chen
2012-01-01
Abstract:The invention discloses Chinese medicine combination for preventing and curing lung injury and pulmonary fibrosis and a preparation method thereof. The Chinese medicine combination comprises the following components in percentage by weight: 28.6 percent of balloonflower root, 28.6 percent of Zhejiang fritillary bulb, 21.4 percent of flos lonicerae, and 21.4 percent of moutan bark; the method for preparing oral liquid comprises the following steps: weighing all the components in percentage by weight, mixing and smashing the components through a 100-mesh sieve, adding mixed powder into a container, adding 500 ml of water into the container, boiling the water and then keeping boiling for 45 minutes, precipitating, filtering, fetching filtrate to be conducted to vacuum concentration to 100 ml, filling concentrated solution into bottles, ensuring that each bottle is 100 milliliters, and then performing sterilizing sealing; the method for preparing capsules comprises the following steps: weighing all the components in percentage by weight, mixing and smashing the components through a 100-mesh sieve, boiling 3/4 of the medicine for 45 mutinies, precipitating, filtering, fetching filtrate to be conducted to vacuum concentration to 100 ml, smashing 1/4 of the medicine again through a 200-mesh sieve to be uniformly mixed with the liquid medicine, performing vacuum drying or low-temperature drying, sterilizing, encapsulating, and ensuring that each capsule is 0.25 g. The Chinese medicine combination ensures that lung is prevented from chemotherapeutics injury and radiation injury, is resistant to pulmonary fibrosis, and does not have toxic side effect and untoward effect.
What problem does this paper attempt to address?